Market Overview
The Pediatric Spasticity Treatment Market is projected to grow significantly, rising from USD 1,160 million in 2024 to an estimated USD 2,450.62 million by 2032, reflecting a compound annual growth rate (CAGR) of 9.8% during the forecast period. This rapid expansion is primarily driven by the increasing prevalence of pediatric spasticity conditions, such as cerebral palsy and other neuromuscular disorders, which affect the movement, coordination, and quality of life of children gl